Clinical Activity of Afatinib in Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Activity of Afatinib in Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study

Published:2020-09 Issue:5 Volume:21 Page:428-436.e2
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Moran Teresa,Taus Alvaro,Arriola Edurne,Aguado Carlos,Dómine Manuel,Rueda Ana Gómez,Calles Antonio,Cedrés Susana,Viñolas Nuria,Isla Dolores,Palmero Ramón,Sereno María,Diaz Victor,Juan Oscar,Marsé Raquel,Martorell Paloma Martín,Sánchez Torres José Miguel,Anguera Georgia,Bosch Joaquim,Cabezón Luis,Catot Silvia,Martinez Alex,Muñoz Silvia,Ramos Inmaculada

Funder

BMS

Roche

MSD

Boehriger Ingelheim

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference55 articles.

1. Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer;Mitsudomi;Cancer Sci,2007

2. Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non–small-cell lung cancer harboring EGFR exon 20 mutations;Chen;Onco Targets Ther,2016

3. Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non–small cell lung cancer patients;Chen;Cancer Chemother Pharmacol,2017

4. Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A;Chiba;BMC Cancer,2017

5. Clinical features and treatment outcome of non–small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations;Frega;Oncotarget,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Adenocarcinoma Patient with Complex Mutations on EGFR Benefits from Furmonertinib after Acquiring Gefitinib Resistance: A Case Report;Recent Patents on Anti-Cancer Drug Discovery;2024-05

2. Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art;Cancers;2024-03-29

3. Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer;Clinical and Translational Oncology;2023-08-11

4. Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis;The Oncologist;2023-04-28

5. Real‐world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi‐center study;Cancer Science;2023-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3